Hypertension, Vol 23, 450-455, Copyright © 1994 by American Heart Association
H Tomiyama, T Kushiro, H Abeta, T Ishii, A Takahashi, L Furukawa, T Asagami, T Hino, F Saito and Y Otsuka
Although angiotensin converting enzyme inhibitors and alpha 1-blockers have
been reported to improve insulin sensitivity, their mechanisms of action
have not been elucidated. To investigate the role of kinins in insulin
sensitivity, we treated 4-week-old spontaneously hypertensive rats with
either an angiotensin converting enzyme inhibitor (enalapril), an alpha
1-blocker (doxazosin), or an angiotensin II antagonist (losartan) for 3
weeks. A control group received no drugs. In addition, 18 rats treated with
enalapril or doxazosin received a simultaneous administration of a kinin
antagonist (Hoe 140). Glucose clamp testing was performed in each group.
Enalapril (128 +/- 1 mmHg) and doxazosin (132 +/- 2 mmHg) decreased mean
blood pressure compared with control levels (148 +/- 1 mmHg) (P < .01).
The glucose requirement for the clamp test during the administration of
enalapril (25.8 +/- 0.5 mg/kg per minute) or doxazosin (28.6 +/- 0.7 mg/kg
per minute) was higher than that of the control group (19.8 +/- 0.5 mg/kg
per minute) (P < .05). Although Hoe 140 did not alter the glucose
requirement of doxazosin (27.8 +/- 0.5 mg/kg per minute), it decreased that
of enalapril (22.6 +/- 0.9 mg/kg per minute) (P < .05) without affecting
the changes in mean blood pressure induced by enalapril. In addition,
losartan decreased mean blood pressure but did not affect the glucose
requirement. Thus, the improvement in insulin sensitivity produced by an
angiotensin converting enzyme inhibitor is mostly dependent on kinins but
not on angiotensin II antagonism, and an alpha 1-blocker improves insulin
sensitivity irrespective of kinins.
ARTICLES
Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor
Department of Cardiology, Surugadai Nihon University Hospital, Tokyo, Japan.
This article has been cited by other articles:
![]() |
A. Duka, E. Kintsurashvili, I. Duka, D. Ona, T. A. Hopkins, M. Bader, I. Gavras, and H. Gavras Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors Hypertension, May 1, 2008; 51(5): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Wong, L. Szeto, K. Uffelman, I G. Fantus, and G. F Lewis Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway. J. Endocrinol., August 1, 2006; 190(2): 441 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abuissa, P. G. Jones, S. P. Marso, and J. H. O'Keefe Jr Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials J. Am. Coll. Cardiol., September 6, 2005; 46(5): 821 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Benson, H. A. Pershadsingh, C. I. Ho, A. Chittiboyina, P. Desai, M. Pravenec, N. Qi, J. Wang, M. A. Avery, and T. W. Kurtz Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR{gamma}-Modulating Activity Hypertension, May 1, 2004; 43(5): 993 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yavuz, M. Koc, A. Toprak, I. Akp{iota}nar, A. Velioglu, O. Deyneli, G. Haklar, and S. Akalln Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 197 - 203. [Abstract] [PDF] |
||||
![]() |
E. Vermes, A. Ducharme, M. G. Bourassa, M. Lessard, M. White, and J.-C. Tardif Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Circulation, March 11, 2003; 107(9): 1291 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Refsgaard, C. Thomsen, F. Andreasen, and O. Gotzsche Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure Eur J Heart Fail, August 1, 2002; 4(4): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogihara, T. Asano, K. Ando, H. Sakoda, M. Anai, N. Shojima, H. Ono, Y. Onishi, M. Fujishiro, M. Abe, et al. High-Salt Diet Enhances Insulin Signaling and Induces Insulin Resistance in Dahl Salt-Sensitive Rats Hypertension, July 1, 2002; 40(1): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Dumke, J. Kim, E. B. Arias, and G. D. Cartee Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions J Appl Physiol, February 1, 2002; 92(2): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Duka, S. Shenouda, C. Johns, E. Kintsurashvili, I. Gavras, and H. Gavras Role of the B2 Receptor of Bradykinin in Insulin Sensitivity Hypertension, December 1, 2001; 38(6): 1355 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. d. O. Prada, M. M. Okamoto, L. N. S. Furukawa, U. F. Machado, J. C. Heimann, and M. S. Dolnikoff High- or Low-Salt Diet From Weaning to Adulthood : Effect on Insulin Sensitivity in Wistar Rats Hypertension, January 1, 2000; 35(1): 424 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tomiyama, Y. Kimura, H. Mitsuhashi, T. Kinouchi, H. Yoshida, T. Kushiro, and N. Doba Relationship Between Endothelial Function and Fibrinolysis in Early Hypertension Hypertension, January 1, 1998; 31(1): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text] |
||||
![]() |
T. Rosenthal, Y. Erlich, E. Rosenmann, and A. Cohen Effects of Enalapril, Losartan, and Verapamil on Blood Pressure and Glucose Metabolism in the Cohen-Rosenthal Diabetic Hypertensive Rat Hypertension, June 1, 1997; 29(6): 1260 - 1264. [Abstract] [Full Text] |
||||
![]() |
Y. Erlich and T. Rosenthal Contribution of Nitric Oxide to the Beneficial Effects of Enalapril in the Fructose-Induced Hyperinsulinemic Rat Hypertension, November 1, 1996; 28(5): 754 - 757. [Abstract] [Full Text] |
||||
![]() |
M. Laakso, L. Karjalainen, and P. Lempiainen-Kuosa Effects of Losartan on Insulin Sensitivity in Hypertensive Subjects Hypertension, September 1, 1996; 28(3): 392 - 396. [Abstract] [Full Text] |
||||
![]() |
B. Jover, A. Herizi, and A. Mimran Chronic Kinin Blockade and Effect of Ramipril in Renal Adaptation to Sodium Restriction Hypertension, January 1, 1996; 27(1): 79 - 84. [Abstract] [Full Text] |
||||
![]() |
O. Kohlman Jr, F. de Assis Rocha Neves, M. Ginoza, A. Tavares, M. L. Cezaretti, M. T. Zanella, A. B. Ribeiro, I. Gavras, and H. Gavras Role of Bradykinin in Insulin Sensitivity and Blood Pressure Regulation During Hyperinsulinemia Hypertension, May 1, 1995; 25(5): 1003 - 1007. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |